Aardvark Therapeutics, Inc. entered into retention bonus agreements with CFO/COO Nelson Sun and CMO Dr. Manasi Jaiman on June 10, 2026. Mr. Sun is entitled to a $346,500 cash bonus, including a $198,000 annual bonus and $153,000 retention bonus, payable on January 1, 2027. Dr. Jaiman is entitled to a $357,000 cash bonus, including a $204,000 annual bonus and $153,000 retention bonus, payable on January 1, 027. Aardvark Therapeutics, Inc. is a biotechnology company focused on developing therapeutic solutions.